Persistently elevated CMI levels are significantly associated with an increased risk of incident CVD among middle-aged and older adults and contribute to reducing CVD incidence and improving prognosis.
Abstract
Purpose No evidence exists regarding the association of long-term cardiometabolic index (CMI) changes with cardiovascular disease (CVD). Our aim is to investigate the association and dose-response relationship between cumulative and long-term changes of CMI and incident CVD risk. Materials and methods The study participants were drawn from the China Health and Retirement Longitudinal Survey (CHARLS) and English Longitudinal Study of Ageing (ELSA) cohorts, and Electronic Medical Records (EMR) in a hospital of Inner Mongolia, China. K-means clustering was used to identify CMI change patterns. Cox proportional hazards models were employed to assess the association between cumulative CMI and CMI change patterns and incident CVD risk. Restricted cubic spline (RCS) analysis was used to account for the nonlinear relationship of cumulative CMI. Results Univariate Cox models revealed a significantly higher CVD incidence risk in the higher CMI trajectory groups. This association remained significant after adjusted. Compared with the lowest CMI group, the hazard ratios (HR) for incident CVD in the highest CMI group were 1.82 (95% CI: 1.47–2.26), 1.92 (95% CI: 1.30–2.85), and 2.00 (95% CI: 1.45–2.76) in the three cohorts, respectively. Cumulative CMI was associated with increased CVD risk, with HR of 1.05 (95% CI: 1.01–1.09), 1.15 (95% CI: 1.07–1.23), and 1.04 (95% CI: 1.01–1.07), respectively, and a nonlinear dose-response relationship was observed. Conclusion Persistently elevated CMI levels are significantly associated with an increased risk of incident CVD among middle-aged and older adults. Long-term monitoring and management of CMI contribute to reducing CVD incidence and improving prognosis.
The modified cardiometabolic index (MCMI) has been proven to be closely associated with cardiovascular disease (CVD). However, most previous studies relied on single-point MCMI measurements, lacking comprehensive evaluations of long-term cumulative exposure and dynamic trajectories. This study aimed to investigat...
Background Cardiometabolic multimorbidity (CMM) is a growing concern as global population ages. Although baseline depression is a recognised risk factor for chronic diseases, the dynamic and cumulative effect of depression on CMM remains unclear. We aimed to evaluate the longitudinal association between long-term depre...
Meng-Han Yao, Zi-Liang Zhang, Jia-Li Zhang et al.· Journal of Global Health· 0 citations
Cardiometabolic multimorbidity (CMM) is an increasing public health concern in ageing populations. Although individual residential environmental factors have been linked to cardiometabolic health, the association of multidimensional living environmental quality with incident CMM remains unclear. We aimed to const...
Hao Chen, Sheng-Nan Yue, Sheng-Yan Hou et al.· BMC Public Health· 0 citations
Cardiometabolic multimorbidity (CMM) is an increasing public health challenge in aging populations. The cholesterol–high-density lipoprotein–glucose (CHG) index is an emerging metabolic marker, but its association with prevalent CMM has not been sufficiently evaluated across community and hospitalized populations....
Ze-Xu Cui, Tian-Hao Lan, Min-Chin Lu et al.· Frontiers in Public Health· 0 citations
Cardiovascular disease (CVD) is a major global health burden. Traditional indicators inadequately capture CVD risk. This study evaluated the association between dynamic changes in novel obesity- and lipid-related indices and CVD incidence.
A prospective cohort study was conducted with 19,315 CVD-free partici...
Jin-Long You, Wu-Zhou Ding, Xue Wang et al.· Frontiers in Endocrinology· 0 citations
BACKGROUND
The cardiometabolic index (CMI), a composite marker derived from the product of waist-to-height ratio and triglyceride-to- high-density lipoprotein cholesterol ratio, has emerged as a potential indicator of metabolic risk. However, the prognostic value of the CMI across diverse populations and the continuum...
Zhen-Yu Liu, Zhi-Xin Li, Si-Yan Huo et al.· Heart, Lung and Circulation· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.